Hester Bios

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,240.15",
    "chg": 134.95,
    "chgp": "6.41%",
    "dir": 1,
    "prev_price": "2,105.20",
    "mcapval": "1,847.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Jun 24, 03:30 PM",
    "curr_time": "04:24 AM",
    "last_traded_at": "Jun 24, 03:30 PM IST",
    "bse_nse_vol": "49.33 k",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-hold-by-marketsmojo-4065200",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_mojoScore_4065200.png",
        "date": "2026-06-20 10:10:03",
        "description": "Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4058055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4058055.png",
        "date": "2026-06-17 08:01:35",
        "description": "Hester Biosciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance across key indicators. Despite a slight dip in the daily price, the stock’s weekly and monthly technical parameters suggest strengthening momentum, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-strong-price-gains-4054905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4054905.png",
        "date": "2026-06-16 08:01:49",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, reflected in a 5.57% surge in its share price to ₹2,069.50 on 16 Jun 2026. This price movement accompanies a technical rating upgrade from Sell to Hold, signalling a cautiously optimistic outlook amid mixed indicator signals across weekly and monthly timeframes."
      },
      {
        "title": "Hester Biosciences Declines 1.83%: Mixed Signals and Technical Shifts Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-declines-183-mixed-signals-and-technical-shifts-shape-the-week-4053023",
        "imagepath": "",
        "date": "2026-06-14 13:00:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> MarketsMOJO downgraded Hester Biosciences Ltd to Sell amid mixed financial and technical signals</p>\n                    <p><strong>2 June:</strong> Technical momentum shifted from mildly bullish to sideways trend</p>\n                    <p><strong>3 June:</strong> Technical momentum shifted again, this time to mildly bullish</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.1,964.35, down 1.83% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,000.95</div></div>\n                    <div class=\"stat-item\"..."
      },
      {
        "title": "Hester Biosciences Ltd’s Mixed Week: -0.20% Price Change Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltds-mixed-week--020-price-change-amid-technical-upgrades-4051578",
        "imagepath": "",
        "date": "2026-06-13 14:05:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Stock opens at Rs.1,968.75 with a 0.22% gain despite Sensex decline</p>\n                    <p><strong>9 Jun:</strong> MarketsMOJO upgrades Hester Biosciences to Hold on improved fundamentals</p>\n                    <p><strong>10 Jun:</strong> Technical momentum shifts to sideways amid mixed signals; stock dips 1.09%</p>\n                    <p><strong>11 Jun:</strong> Golden Cross forms, signalling potential bullish breakout; stock rebounds 0.91%</p>\n                    <p><strong>12 Jun:</strong> Bullish momentum continues with technical upgrades; stock closes at Rs.1,960.40 (+0.42%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n             ..."
      },
      {
        "title": "Hester Biosciences Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-shows-bullish-momentum-amid-technical-upgrades-4048242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4048242.png",
        "date": "2026-06-12 08:01:15",
        "description": "Hester Biosciences Ltd has transitioned from a sideways technical trend to a bullish momentum phase, supported by a series of positive signals across key technical indicators. The micro-cap pharmaceutical and biotechnology company’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and a strengthening price structure, with notable gains outpacing the broader Sensex over multiple timeframes."
      },
      {
        "title": "Golden Cross Forms in Hester Biosciences Ltd Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4047100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_goldencross_4047100.png",
        "date": "2026-06-11 18:00:25",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Hester Biosciences Ltd, signalling a golden cross on 11 Jun 2026. Yet, the broader technical and fundamental picture presents a nuanced view that tempers the enthusiasm typically associated with this event."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4043221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4043221.png",
        "date": "2026-06-10 08:01:46",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in daily moving averages to mildly bearish, weekly and monthly signals present a nuanced picture for investors navigating this pharmaceuticals and biotechnology micro-cap."
      },
      {
        "title": "Hester Biosciences Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financials-4040446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_mojoScore_4040446.png",
        "date": "2026-06-09 08:32:32",
        "description": "Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a combination of improved technical indicators, solid recent financial performance, and a more favourable valuation outlook. The upgrade, effective from 8 June 2026, is underpinned by positive shifts across four key parameters: quality, valuation, financial trend, and technicals."
      }
    ],
    "total": 5481,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-Jun-2026",
      "details": "Copies of newspaper advertisement for 39th Annual General Meeting",
      "source": "BSE"
    },
    {
      "caption": "Hesters 39Th Annual General Meeting To Be Held On 21 July 2026",
      "datetime": "18-Jun-2026",
      "details": "Hesters 39th Annual General Meeting to be held on 21 July 2026 through Video Conference/ Other Audio Visual Means. Hesters 39th Annual Report 2025-26 and AGM notice attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Record Date For Dividend And Meeting",
      "datetime": "18-Jun-2026",
      "details": "Record date for Dividend and AGM is Tuesday 14 July 2026 for the purpose of determining shareholders entitlement for dividend as recommended by the Board of Directors at their meeting held on 15 May 2026 on the equity shares at the rate of 110% ( i.e. INR 11 per share) for the Financial Year 2025-26 subject to the approval of members at the ensuing general meeting. Cut-off date for the purpose of determining the members eligible for vote on resolutions set out in the notice of the AGM.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>110%</strong> dividend, ex-date: 14 Jul 26",
          "dt": "2026-07-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd is Rated Hold by MarketsMOJO

2026-06-20 10:10:03

Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-17 08:01:35

Hester Biosciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance across key indicators. Despite a slight dip in the daily price, the stock’s weekly and monthly technical parameters suggest strengthening momentum, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Hester Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains

2026-06-16 08:01:49

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, reflected in a 5.57% surge in its share price to ₹2,069.50 on 16 Jun 2026. This price movement accompanies a technical rating upgrade from Sell to Hold, signalling a cautiously optimistic outlook amid mixed indicator signals across weekly and monthly timeframes.

Read full news article

Hester Biosciences Declines 1.83%: Mixed Signals and Technical Shifts Shape the Week

2026-06-14 13:00:55

Key Events This Week

1 June: MarketsMOJO downgraded Hester Biosciences Ltd to Sell amid mixed financial and technical signals

2 June: Technical momentum shifted from mildly bullish to sideways trend

3 June: Technical momentum shifted again, this time to mildly bullish

5 June: Week closes at Rs.1,964.35, down 1.83% for the week

Week Open

Rs.2,000.95

Read full news article

Hester Biosciences Ltd’s Mixed Week: -0.20% Price Change Amid Technical Upgrades

2026-06-13 14:05:12

Key Events This Week

8 Jun: Stock opens at Rs.1,968.75 with a 0.22% gain despite Sensex decline

9 Jun: MarketsMOJO upgrades Hester Biosciences to Hold on improved fundamentals

10 Jun: Technical momentum shifts to sideways amid mixed signals; stock dips 1.09%

11 Jun: Golden Cross forms, signalling potential bullish breakout; stock rebounds 0.91%

12 Jun: Bullish momentum continues with technical upgrades; stock closes at Rs.1,960.40 (+0.42%)

...

Read full news article

Hester Biosciences Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-06-12 08:01:15

Hester Biosciences Ltd has transitioned from a sideways technical trend to a bullish momentum phase, supported by a series of positive signals across key technical indicators. The micro-cap pharmaceutical and biotechnology company’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and a strengthening price structure, with notable gains outpacing the broader Sensex over multiple timeframes.

Read full news article

Golden Cross Forms in Hester Biosciences Ltd Amid Mixed Technical Signals

2026-06-11 18:00:25

The 50-day moving average has crossed above the 200-day moving average for Hester Biosciences Ltd, signalling a golden cross on 11 Jun 2026. Yet, the broader technical and fundamental picture presents a nuanced view that tempers the enthusiasm typically associated with this event.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-10 08:01:46

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in daily moving averages to mildly bearish, weekly and monthly signals present a nuanced picture for investors navigating this pharmaceuticals and biotechnology micro-cap.

Read full news article

Hester Biosciences Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials

2026-06-09 08:32:32

Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a combination of improved technical indicators, solid recent financial performance, and a more favourable valuation outlook. The upgrade, effective from 8 June 2026, is underpinned by positive shifts across four key parameters: quality, valuation, financial trend, and technicals.

Read full news article

View All News